Multimodality treatment of intrahepatic cholangiocarcinoma: A review

摘要

Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary hepatic cancer in the United States. Currently, curative treatment involves aggressive surgery. Chemotherapy and radiation treatments have been used for unresectable tumors with some success. Optimizing the use of current and developing novel multimodality treatment for iCCA is essential to improving outcomes. J. Surg. Oncol. 2016;113:62-83. (c) 2016 Wiley Periodicals, Inc.